Casdin Capital’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,050,000
Closed -$7.67M 38
2023
Q4
$7.67M Hold
2,050,000
0.76% 25
2023
Q3
$4.35M Hold
2,050,000
0.48% 27
2023
Q2
$9.76M Hold
2,050,000
0.85% 25
2023
Q1
$11.7M Hold
2,050,000
0.97% 26
2022
Q4
$20.7M Hold
2,050,000
1.62% 18
2022
Q3
$45.9M Sell
2,050,000
-50,000
-2% -$1.44M 3.03% 11
2022
Q2
$52M Sell
2,100,000
-1,300,000
-38% -$35.9M 4.4% 8
2022
Q1
$132M Hold
3,400,000
5.91% 4
2021
Q4
$199M Hold
3,400,000
5.61% 3
2021
Q3
$202M Hold
3,400,000
5.03% 5
2021
Q2
$295M Hold
3,400,000
7.49% 3
2021
Q1
$280M Buy
3,400,000
+350,000
+11% +$33.5M 8.35% 3
2020
Q4
$277M Hold
3,050,000
8.25% 3
2020
Q3
$122M Hold
3,050,000
5.46% 5
2020
Q2
$105M Buy
3,050,000
+500,000
+20% +$14.9M 6.19% 3
2020
Q1
$56.6M Hold
2,550,000
6.01% 4
2019
Q4
$49.9M Hold
2,550,000
4.64% 10
2019
Q3
$39.6M Hold
2,550,000
4.1% 11
2019
Q2
$51.8M Hold
2,550,000
4.85% 7
2019
Q1
$44.8M Hold
2,550,000
4.92% 7
2018
Q4
$32.7M Hold
2,550,000
5.6% 7
2018
Q3
$41.5M Sell
2,550,000
-50,000
-2% -$591K 5.1% 7
2018
Q2
$29.5M Hold
2,600,000
4.16% 9
2018
Q1
$25.4M Hold
2,600,000
4.49% 11
2017
Q4
$15.9M Buy
2,600,000
+2,050,000
+373% +$9.15M 3.88% 12
2017
Q3
$2.18M Hold
550,000
0.62% 25
2017
Q2
$1.78M Buy
+550,000
New +$2.11M 0.71% 32

Other funds holding FATE